BDBM621030 (6-((4-(2-(diethylamino)benzothiazole-6-yl)-5-fluoropyrimidine-2-yl)amino)pyridine-3-yl)(piperazine-1-yl)ketonehydrochloride::US20230303553, Example 47

SMILES CCN(CC)c1nc2ccc(cc2s1)-c1nc(Nc2ccc(cn2)C(=O)N2CCNCC2)ncc1F

InChI Key InChIKey=QULVCQWDONFUCP-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 621030   

TargetCyclin-dependent kinase 6(Human)
Jiangsu Tasly Diyi Pharmaceutical

US Patent
LigandPNGBDBM621030(US20230303553, Example 47 | (6-((4-(2-(diethylamin...)
Affinity DataIC50: 39nMAssay Description:Table 1: In the test plate, protein kinase, Ulight-labeled polypeptide substrate, ATP, and the compounds were mixed and the reaction was incubated. E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Human)
Jiangsu Tasly Diyi Pharmaceutical

US Patent
LigandPNGBDBM621030(US20230303553, Example 47 | (6-((4-(2-(diethylamin...)
Affinity DataIC50: 39nMAssay Description:The DYRK2 kinase inhibitory activity of the compounds of the invention were measured. The method was briefly described as follows (for specific metho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Human)
Jiangsu Tasly Diyi Pharmaceutical

US Patent
LigandPNGBDBM621030(US20230303553, Example 47 | (6-((4-(2-(diethylamin...)
Affinity DataIC50: 39nMAssay Description:Inhibition of DYRK2 (unknown origin) incubated for 120 mins in presence of 33P-ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed